Disturbed secretion of mutant adiponectin associated with the metabolic syndrome
Ken Kishida(The University of Osaka), Yūji Matsuzawa(Sumitomo Hospital), Kazuhisa Maeda(Shiseido Group (Japan)), Hiroyuki Nagaretani(The University of Osaka), Toshiyuki Hibuse(The University of Osaka), Noriyuki Ouchi(Nagoya University), Yoshihisa Okamoto(Japan Tobacco (United States)), Norikazu Maeda(The University of Osaka), Hideki Kobayashi(The University of Osaka), Koji Ohashi(Fujita Health University), Azumi Nagasawa(The University of Osaka), Shinji Kihara(University of Copenhagen), Sachiyo Tanaka(Nippon Veterinary and Life Science University), Hidehiko Kondo(Kao Corporation (Japan)), Hitoshi Nishizawa(Osaka Gakuin University), Tohru Funahashi(The University of Osaka), Masahiro Kumada(The University of Osaka)
Cited by 74
Related Papers
Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia
|The Journal of Clinical Endocrinology & Metabolism|2001|3.4k
Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin
|The Journal of Clinical Endocrinology & Metabolism|2001|1.2k
Adiponectin and development of type 2 diabetes in the Pima Indian population
|The Lancet|2002|1.1k
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
|Journal of Atherosclerosis and Thrombosis|2018|821